Genevieve Sparagna
Concepts (369)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiolipins | 38 | 2026 | 82 | 4.320 |
Why?
| | Myocardium | 22 | 2025 | 947 | 1.900 |
Why?
| | Mitochondria, Heart | 19 | 2026 | 107 | 1.760 |
Why?
| | Linoleic Acid | 8 | 2026 | 44 | 1.150 |
Why?
| | Mitochondria | 20 | 2025 | 1000 | 1.100 |
Why?
| | Phospholipids | 11 | 2024 | 214 | 0.880 |
Why?
| | Acyltransferases | 12 | 2025 | 78 | 0.830 |
Why?
| | Heart Failure | 12 | 2016 | 2334 | 0.720 |
Why?
| | Barth Syndrome | 4 | 2022 | 9 | 0.710 |
Why?
| | Myocytes, Cardiac | 8 | 2026 | 547 | 0.670 |
Why?
| | Fatty Acids | 11 | 2025 | 461 | 0.570 |
Why?
| | Rats | 26 | 2022 | 5613 | 0.470 |
Why?
| | Palmitic Acid | 4 | 2004 | 40 | 0.460 |
Why?
| | Electron Transport Complex III | 7 | 2017 | 18 | 0.460 |
Why?
| | Mitochondria, Liver | 6 | 2017 | 70 | 0.450 |
Why?
| | Liver | 6 | 2026 | 1916 | 0.450 |
Why?
| | Diet, High-Fat | 4 | 2021 | 267 | 0.440 |
Why?
| | Energy Metabolism | 5 | 2026 | 936 | 0.440 |
Why?
| | Apoptosis | 8 | 2009 | 2454 | 0.400 |
Why?
| | Animals | 52 | 2026 | 38410 | 0.390 |
Why?
| | Animal Feed | 2 | 2013 | 50 | 0.390 |
Why?
| | Rats, Inbred SHR | 9 | 2013 | 36 | 0.380 |
Why?
| | Body Weight | 7 | 2025 | 976 | 0.360 |
Why?
| | Reactive Oxygen Species | 4 | 2025 | 616 | 0.350 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2009 | 124 | 0.340 |
Why?
| | Berberine | 2 | 2021 | 5 | 0.340 |
Why?
| | Mitochondrial Trifunctional Protein, alpha Subunit | 2 | 2025 | 3 | 0.340 |
Why?
| | Mitochondria, Muscle | 2 | 2025 | 125 | 0.330 |
Why?
| | Electron Transport Complex IV | 4 | 2012 | 61 | 0.320 |
Why?
| | Calcium | 9 | 2010 | 1197 | 0.310 |
Why?
| | Phospholipases A2, Calcium-Independent | 1 | 2009 | 18 | 0.300 |
Why?
| | Cardiomyopathies | 2 | 2025 | 339 | 0.300 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2021 | 144 | 0.290 |
Why?
| | Fatty Liver | 2 | 2026 | 257 | 0.290 |
Why?
| | Fundulidae | 2 | 2018 | 2 | 0.280 |
Why?
| | Saccharomyces cerevisiae | 3 | 2023 | 584 | 0.270 |
Why?
| | Myocardial Reperfusion Injury | 3 | 2013 | 139 | 0.270 |
Why?
| | Mitochondrial Membranes | 3 | 2025 | 40 | 0.260 |
Why?
| | Diet | 3 | 2023 | 1284 | 0.260 |
Why?
| | Oxidation-Reduction | 11 | 2021 | 1077 | 0.260 |
Why?
| | Ischemia | 4 | 2024 | 424 | 0.260 |
Why?
| | Diabetes, Gestational | 2 | 2021 | 307 | 0.250 |
Why?
| | Dietary Fats | 5 | 2023 | 309 | 0.250 |
Why?
| | Mitochondrial Trifunctional Protein | 2 | 2025 | 5 | 0.250 |
Why?
| | Enzyme Inhibitors | 5 | 2013 | 822 | 0.240 |
Why?
| | Acclimatization | 2 | 2018 | 170 | 0.240 |
Why?
| | Oligopeptides | 2 | 2025 | 267 | 0.240 |
Why?
| | Electron Transport Complex I | 3 | 2021 | 42 | 0.240 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2026 | 40 | 0.240 |
Why?
| | Juglans | 1 | 2025 | 8 | 0.230 |
Why?
| | Nuts | 1 | 2025 | 13 | 0.230 |
Why?
| | Mitochondrial Membrane Transport Proteins | 4 | 2010 | 46 | 0.230 |
Why?
| | Soybean Oil | 1 | 2025 | 15 | 0.230 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2012 | 176 | 0.230 |
Why?
| | Rats, Sprague-Dawley | 10 | 2009 | 2542 | 0.230 |
Why?
| | Food, Fortified | 1 | 2025 | 44 | 0.230 |
Why?
| | Disease | 1 | 2006 | 96 | 0.230 |
Why?
| | Long-Chain-3-Hydroxyacyl-CoA Dehydrogenase | 1 | 2025 | 3 | 0.220 |
Why?
| | Heart | 4 | 2017 | 628 | 0.220 |
Why?
| | Purpura | 1 | 2025 | 18 | 0.220 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2025 | 20 | 0.220 |
Why?
| | Postprandial Period | 1 | 2025 | 115 | 0.220 |
Why?
| | Docosahexaenoic Acids | 3 | 2017 | 90 | 0.220 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2023 | 415 | 0.210 |
Why?
| | Transcription Factors | 6 | 2022 | 1747 | 0.210 |
Why?
| | Mice, Inbred C57BL | 7 | 2025 | 6041 | 0.210 |
Why?
| | Male | 31 | 2026 | 73950 | 0.190 |
Why?
| | Cardiomyopathy, Dilated | 3 | 2014 | 358 | 0.190 |
Why?
| | Glutathione | 1 | 2024 | 370 | 0.180 |
Why?
| | Escherichia coli Proteins | 1 | 2024 | 201 | 0.180 |
Why?
| | Mice | 14 | 2025 | 18491 | 0.180 |
Why?
| | Cells, Cultured | 9 | 2026 | 4169 | 0.170 |
Why?
| | Fatty Acids, Unsaturated | 3 | 2021 | 97 | 0.170 |
Why?
| | Heart Diseases | 2 | 2021 | 341 | 0.170 |
Why?
| | Mitochondrial Diseases | 1 | 2022 | 94 | 0.170 |
Why?
| | Cytochrome c Group | 4 | 2001 | 43 | 0.160 |
Why?
| | Palmitates | 1 | 2000 | 21 | 0.160 |
Why?
| | Coenzyme A | 1 | 2020 | 8 | 0.160 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4604 | 0.160 |
Why?
| | Lipid Metabolism | 3 | 2020 | 538 | 0.160 |
Why?
| | Maternal-Fetal Exchange | 1 | 2021 | 171 | 0.160 |
Why?
| | B-Lymphocytes | 2 | 2022 | 878 | 0.150 |
Why?
| | Vascular Remodeling | 1 | 2022 | 209 | 0.150 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 479 | 0.150 |
Why?
| | Heart Ventricles | 3 | 2020 | 767 | 0.150 |
Why?
| | Ethanol | 1 | 2004 | 634 | 0.150 |
Why?
| | Physical Conditioning, Animal | 3 | 2008 | 242 | 0.150 |
Why?
| | Multienzyme Complexes | 2 | 2012 | 65 | 0.140 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 300 | 0.140 |
Why?
| | Animals, Newborn | 6 | 2022 | 914 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2020 | 347 | 0.140 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 375 | 0.140 |
Why?
| | Dietary Supplements | 2 | 2021 | 586 | 0.140 |
Why?
| | Thermotolerance | 1 | 2018 | 8 | 0.140 |
Why?
| | Optic Atrophy, Autosomal Dominant | 1 | 2017 | 1 | 0.130 |
Why?
| | Islets of Langerhans | 2 | 2021 | 853 | 0.130 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 277 | 0.130 |
Why?
| | Dynamins | 1 | 2017 | 37 | 0.130 |
Why?
| | Intermittent Claudication | 1 | 2018 | 122 | 0.130 |
Why?
| | Eicosapentaenoic Acid | 3 | 2017 | 37 | 0.130 |
Why?
| | Mitochondrial Dynamics | 1 | 2017 | 41 | 0.130 |
Why?
| | Female | 20 | 2026 | 80076 | 0.130 |
Why?
| | Cognition | 1 | 2025 | 1286 | 0.130 |
Why?
| | Phosphatidylglycerols | 2 | 2023 | 20 | 0.120 |
Why?
| | Muscle, Skeletal | 2 | 2025 | 1798 | 0.120 |
Why?
| | Biological Transport | 6 | 2024 | 425 | 0.120 |
Why?
| | A Kinase Anchor Proteins | 1 | 2017 | 75 | 0.120 |
Why?
| | Mitochondrial Proteins | 2 | 2016 | 264 | 0.120 |
Why?
| | Phenotype | 3 | 2022 | 3216 | 0.120 |
Why?
| | Blood Pressure | 7 | 2013 | 1785 | 0.120 |
Why?
| | Hypertension | 4 | 2008 | 1280 | 0.120 |
Why?
| | Kidney | 1 | 2024 | 1511 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 880 | 0.120 |
Why?
| | Gene Expression | 4 | 2021 | 1481 | 0.110 |
Why?
| | Sirtuins | 1 | 2016 | 50 | 0.110 |
Why?
| | Signal Transduction | 5 | 2021 | 5272 | 0.110 |
Why?
| | Temperature | 1 | 2018 | 638 | 0.110 |
Why?
| | Electron Transport | 4 | 2021 | 110 | 0.110 |
Why?
| | Huntington Disease | 1 | 2016 | 61 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 480 | 0.110 |
Why?
| | Humans | 24 | 2026 | 147293 | 0.110 |
Why?
| | Caspases | 4 | 2013 | 233 | 0.110 |
Why?
| | Linoleoyl-CoA Desaturase | 1 | 2013 | 2 | 0.100 |
Why?
| | Lymphocytes | 1 | 2016 | 378 | 0.100 |
Why?
| | Mice, Transgenic | 4 | 2021 | 2197 | 0.100 |
Why?
| | Spectrometry, Fluorescence | 1 | 1994 | 166 | 0.100 |
Why?
| | Oleic Acid | 3 | 2022 | 40 | 0.100 |
Why?
| | Cross-Over Studies | 2 | 2025 | 617 | 0.100 |
Why?
| | Cell Differentiation | 1 | 2021 | 2054 | 0.090 |
Why?
| | Safflower Oil | 1 | 2012 | 4 | 0.090 |
Why?
| | Oxidative Stress | 3 | 2025 | 1368 | 0.090 |
Why?
| | Aging | 3 | 2008 | 1992 | 0.090 |
Why?
| | Lysophospholipids | 2 | 2012 | 80 | 0.090 |
Why?
| | Citrate (si)-Synthase | 3 | 2007 | 57 | 0.090 |
Why?
| | Echocardiography | 5 | 2020 | 652 | 0.090 |
Why?
| | Peripheral Arterial Disease | 1 | 2018 | 510 | 0.090 |
Why?
| | Electron Transport Complex II | 1 | 2011 | 27 | 0.090 |
Why?
| | Myocardial Contraction | 1 | 2013 | 293 | 0.080 |
Why?
| | Leukocytes, Mononuclear | 2 | 2026 | 590 | 0.080 |
Why?
| | Time Factors | 4 | 2009 | 7173 | 0.080 |
Why?
| | Cryoelectron Microscopy | 1 | 2012 | 223 | 0.080 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2011 | 152 | 0.080 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2001 | 49 | 0.080 |
Why?
| | Mass Spectrometry | 3 | 2017 | 728 | 0.080 |
Why?
| | Nutritional Status | 1 | 2013 | 353 | 0.080 |
Why?
| | Persistent Fetal Circulation Syndrome | 1 | 2011 | 139 | 0.080 |
Why?
| | Ceramides | 2 | 2001 | 117 | 0.080 |
Why?
| | Tissue Survival | 1 | 2009 | 16 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2218 | 0.080 |
Why?
| | Metabolomics | 2 | 2026 | 736 | 0.070 |
Why?
| | Fish Oils | 1 | 2009 | 27 | 0.070 |
Why?
| | Diacylglycerol Cholinephosphotransferase | 1 | 2008 | 1 | 0.070 |
Why?
| | Cytidine Diphosphate Diglycerides | 1 | 2008 | 3 | 0.070 |
Why?
| | Transferases (Other Substituted Phosphate Groups) | 1 | 2008 | 3 | 0.070 |
Why?
| | Phosphatidic Acids | 1 | 2008 | 8 | 0.070 |
Why?
| | Aged | 6 | 2026 | 26514 | 0.070 |
Why?
| | Cardiotonic Agents | 1 | 2009 | 94 | 0.070 |
Why?
| | Glycochenodeoxycholic Acid | 1 | 2008 | 14 | 0.070 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 365 | 0.070 |
Why?
| | Glycolysis | 2 | 2024 | 341 | 0.070 |
Why?
| | alpha-Tocopherol | 1 | 2008 | 33 | 0.070 |
Why?
| | Rats, Inbred Strains | 1 | 2008 | 323 | 0.070 |
Why?
| | Superoxides | 2 | 2009 | 199 | 0.070 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2009 | 145 | 0.070 |
Why?
| | Adenosine Triphosphate | 3 | 2016 | 500 | 0.070 |
Why?
| | Cytosol | 2 | 2000 | 213 | 0.070 |
Why?
| | Molecular Structure | 1 | 2009 | 488 | 0.070 |
Why?
| | Calcium-Binding Proteins | 4 | 2008 | 222 | 0.060 |
Why?
| | Blotting, Western | 4 | 2016 | 1186 | 0.060 |
Why?
| | Rats, Wistar | 3 | 2017 | 450 | 0.060 |
Why?
| | Antioxidants | 3 | 2025 | 550 | 0.060 |
Why?
| | Rats, Inbred BN | 1 | 2007 | 56 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 440 | 0.060 |
Why?
| | Phosphatidylethanolamines | 2 | 2017 | 79 | 0.060 |
Why?
| | Membrane Potentials | 2 | 2000 | 278 | 0.060 |
Why?
| | Heart Function Tests | 2 | 2020 | 59 | 0.060 |
Why?
| | Obesity | 2 | 2021 | 3149 | 0.060 |
Why?
| | Middle Aged | 6 | 2026 | 36821 | 0.060 |
Why?
| | Phosphatidylcholines | 2 | 2017 | 131 | 0.060 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2006 | 26 | 0.060 |
Why?
| | Cardiac Output, Low | 1 | 2006 | 53 | 0.060 |
Why?
| | Adult | 6 | 2026 | 41405 | 0.060 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 146 | 0.060 |
Why?
| | Stress, Physiological | 1 | 2009 | 445 | 0.060 |
Why?
| | Palm Oil | 1 | 2025 | 3 | 0.060 |
Why?
| | Hypothyroidism | 1 | 2006 | 68 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2890 | 0.060 |
Why?
| | Syndrome | 1 | 2006 | 385 | 0.060 |
Why?
| | Mitochondrial Myopathies | 1 | 2025 | 10 | 0.060 |
Why?
| | Chromatography, Gas | 1 | 2005 | 30 | 0.060 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2025 | 75 | 0.060 |
Why?
| | Rhabdomyolysis | 1 | 2025 | 24 | 0.050 |
Why?
| | Cyclosporine | 2 | 2009 | 257 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2005 | 125 | 0.050 |
Why?
| | RNA, Messenger | 3 | 2020 | 2812 | 0.050 |
Why?
| | Enzyme Activation | 2 | 2012 | 762 | 0.050 |
Why?
| | Reference Standards | 1 | 2005 | 177 | 0.050 |
Why?
| | Phospholipid Transfer Proteins | 1 | 2024 | 7 | 0.050 |
Why?
| | Escherichia coli K12 | 1 | 2024 | 7 | 0.050 |
Why?
| | Protein Kinase C-epsilon | 1 | 2004 | 23 | 0.050 |
Why?
| | Linoleic Acids | 1 | 2023 | 6 | 0.050 |
Why?
| | Pregnancy | 3 | 2022 | 7274 | 0.050 |
Why?
| | Membrane Proteins | 2 | 2008 | 1171 | 0.050 |
Why?
| | Kinetics | 3 | 1998 | 1569 | 0.050 |
Why?
| | Cell Respiration | 2 | 2017 | 105 | 0.050 |
Why?
| | Oxygen Consumption | 2 | 2021 | 721 | 0.050 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2007 | 394 | 0.050 |
Why?
| | Caspase 3 | 2 | 2002 | 242 | 0.050 |
Why?
| | Models, Cardiovascular | 1 | 2004 | 196 | 0.050 |
Why?
| | Respiration | 1 | 2023 | 208 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2024 | 154 | 0.050 |
Why?
| | Acyl Coenzyme A | 2 | 2013 | 32 | 0.050 |
Why?
| | Protein Kinase C | 1 | 2004 | 251 | 0.050 |
Why?
| | Coronary Circulation | 1 | 2003 | 134 | 0.050 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2004 | 192 | 0.050 |
Why?
| | Cold Temperature | 1 | 2024 | 207 | 0.050 |
Why?
| | Hydrogen Peroxide | 2 | 2020 | 338 | 0.040 |
Why?
| | Glucose | 2 | 2021 | 1051 | 0.040 |
Why?
| | Indomethacin | 1 | 2022 | 77 | 0.040 |
Why?
| | Nervous System Diseases | 1 | 2025 | 288 | 0.040 |
Why?
| | CD40 Antigens | 1 | 2022 | 91 | 0.040 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2024 | 337 | 0.040 |
Why?
| | Interleukin-4 | 1 | 2022 | 207 | 0.040 |
Why?
| | Cell Line | 2 | 2021 | 2832 | 0.040 |
Why?
| | Biomarkers | 2 | 2025 | 4351 | 0.040 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2022 | 156 | 0.040 |
Why?
| | Doxycycline | 1 | 2021 | 62 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2025 | 1147 | 0.040 |
Why?
| | Phenylephrine | 1 | 2021 | 74 | 0.040 |
Why?
| | Mitochondrial Swelling | 1 | 2000 | 1 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2004 | 627 | 0.040 |
Why?
| | Myofibrils | 1 | 2021 | 53 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2020 | 3153 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2025 | 2080 | 0.040 |
Why?
| | Sarcomeres | 1 | 2021 | 101 | 0.040 |
Why?
| | Culture Media | 1 | 2021 | 161 | 0.040 |
Why?
| | Metabolome | 1 | 2024 | 391 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2000 | 62 | 0.040 |
Why?
| | Ruthenium Red | 2 | 2001 | 7 | 0.040 |
Why?
| | Caspase Inhibitors | 1 | 2000 | 81 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2022 | 311 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2002 | 212 | 0.040 |
Why?
| | Spermine | 2 | 2001 | 29 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 334 | 0.040 |
Why?
| | Ion Channels | 1 | 2000 | 129 | 0.040 |
Why?
| | Respiratory Function Tests | 1 | 2022 | 545 | 0.040 |
Why?
| | Escherichia coli | 1 | 2024 | 836 | 0.040 |
Why?
| | Oxidative Phosphorylation | 2 | 2017 | 212 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 2030 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1912 | 0.040 |
Why?
| | Swine | 2 | 2013 | 828 | 0.040 |
Why?
| | Child, Preschool | 3 | 2021 | 12016 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2025 | 1776 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 863 | 0.040 |
Why?
| | Fluorescent Dyes | 1 | 2000 | 342 | 0.040 |
Why?
| | Pancreas | 1 | 2021 | 345 | 0.030 |
Why?
| | Ankle Brachial Index | 1 | 2018 | 41 | 0.030 |
Why?
| | Fibrosis | 1 | 2021 | 568 | 0.030 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 212 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2021 | 443 | 0.030 |
Why?
| | Organ Size | 2 | 2009 | 465 | 0.030 |
Why?
| | Isolated Heart Preparation | 1 | 2017 | 6 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 1999 | 241 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2018 | 94 | 0.030 |
Why?
| | Atrial Natriuretic Factor | 2 | 2009 | 55 | 0.030 |
Why?
| | Ventricular Remodeling | 1 | 2020 | 283 | 0.030 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 773 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2026 | 1253 | 0.030 |
Why?
| | Lipids | 2 | 2012 | 723 | 0.030 |
Why?
| | Enzymes | 1 | 2017 | 60 | 0.030 |
Why?
| | Protein Binding | 2 | 2012 | 2249 | 0.030 |
Why?
| | Myosin Heavy Chains | 2 | 2009 | 183 | 0.030 |
Why?
| | Insulin | 2 | 2021 | 2526 | 0.030 |
Why?
| | Adiposity | 1 | 2021 | 533 | 0.030 |
Why?
| | Lipogenesis | 1 | 2016 | 62 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1730 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2021 | 915 | 0.030 |
Why?
| | Myocardial Infarction | 1 | 2003 | 1213 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 2 | 2008 | 975 | 0.030 |
Why?
| | Hepatocytes | 1 | 2016 | 224 | 0.030 |
Why?
| | Calcium Channels | 3 | 2001 | 157 | 0.030 |
Why?
| | Herpesvirus 4, Human | 1 | 2016 | 173 | 0.030 |
Why?
| | Atherosclerosis | 1 | 2018 | 411 | 0.030 |
Why?
| | Child | 3 | 2021 | 22979 | 0.030 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2016 | 102 | 0.030 |
Why?
| | Egtazic Acid | 1 | 1994 | 37 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2021 | 663 | 0.030 |
Why?
| | Hypoxia | 1 | 2022 | 1208 | 0.030 |
Why?
| | DNA | 1 | 2001 | 1444 | 0.030 |
Why?
| | Age Factors | 2 | 2014 | 3372 | 0.030 |
Why?
| | Automation | 1 | 1994 | 104 | 0.030 |
Why?
| | Infant | 2 | 2021 | 10194 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3660 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1794 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1772 | 0.020 |
Why?
| | Ventricular Function, Left | 2 | 2009 | 546 | 0.020 |
Why?
| | Cytochrome Reductases | 1 | 2012 | 3 | 0.020 |
Why?
| | Palmitoyl Coenzyme A | 1 | 2012 | 2 | 0.020 |
Why?
| | Phospholipases | 1 | 2012 | 14 | 0.020 |
Why?
| | Proteolipids | 1 | 2012 | 28 | 0.020 |
Why?
| | Swine, Miniature | 1 | 2013 | 89 | 0.020 |
Why?
| | Ubiquinone | 1 | 2012 | 36 | 0.020 |
Why?
| | Thyroxine | 1 | 2012 | 67 | 0.020 |
Why?
| | Weight Gain | 1 | 2016 | 566 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2012 | 417 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2012 | 116 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2012 | 362 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2012 | 387 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2011 | 73 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 547 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2012 | 567 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2013 | 308 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2014 | 6543 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 410 | 0.020 |
Why?
| | Models, Chemical | 1 | 2012 | 251 | 0.020 |
Why?
| | RNA Interference | 1 | 2012 | 477 | 0.020 |
Why?
| | Superoxide Dismutase | 2 | 2003 | 308 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2012 | 487 | 0.020 |
Why?
| | Mutation | 1 | 2021 | 4130 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 855 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2012 | 669 | 0.020 |
Why?
| | Thromboxane B2 | 1 | 2009 | 23 | 0.020 |
Why?
| | Constriction | 1 | 2009 | 45 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 980 | 0.020 |
Why?
| | Arachidonic Acid | 1 | 2009 | 102 | 0.020 |
Why?
| | Aorta, Abdominal | 1 | 2009 | 52 | 0.020 |
Why?
| | Cytochromes c | 1 | 2008 | 53 | 0.020 |
Why?
| | Thromboxanes | 1 | 2008 | 14 | 0.020 |
Why?
| | Rats, Mutant Strains | 1 | 2008 | 19 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 2134 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 22825 | 0.020 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2011 | 450 | 0.020 |
Why?
| | Phosphorylation | 1 | 2013 | 1721 | 0.020 |
Why?
| | Hemodynamics | 1 | 2013 | 1127 | 0.020 |
Why?
| | Diet, Fat-Restricted | 1 | 2008 | 79 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 2886 | 0.020 |
Why?
| | Heart Transplantation | 1 | 2014 | 682 | 0.020 |
Why?
| | Dietary Carbohydrates | 1 | 2008 | 147 | 0.020 |
Why?
| | Cell Death | 1 | 2008 | 383 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 6011 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 8430 | 0.010 |
Why?
| | Cytokines | 1 | 2013 | 2086 | 0.010 |
Why?
| | Isomerism | 1 | 2005 | 56 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2011 | 1132 | 0.010 |
Why?
| | Cell Size | 1 | 2005 | 94 | 0.010 |
Why?
| | Proteinuria | 1 | 2005 | 104 | 0.010 |
Why?
| | RNA | 1 | 2011 | 916 | 0.010 |
Why?
| | Cell Separation | 1 | 2005 | 306 | 0.010 |
Why?
| | Exercise Test | 1 | 2007 | 636 | 0.010 |
Why?
| | Leptin | 1 | 2005 | 249 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2012 | 2625 | 0.010 |
Why?
| | Blood Glucose | 1 | 2013 | 2359 | 0.010 |
Why?
| | Ditiocarb | 1 | 2002 | 3 | 0.010 |
Why?
| | Fluoresceins | 1 | 2002 | 48 | 0.010 |
Why?
| | Tibia | 1 | 2003 | 177 | 0.010 |
Why?
| | Survival Analysis | 1 | 2005 | 1386 | 0.010 |
Why?
| | Chelating Agents | 1 | 2002 | 76 | 0.010 |
Why?
| | Calcium Radioisotopes | 1 | 2001 | 1 | 0.010 |
Why?
| | Adenylate Kinase | 1 | 2001 | 26 | 0.010 |
Why?
| | Adenosine Diphosphate | 1 | 2001 | 83 | 0.010 |
Why?
| | Chickens | 1 | 2001 | 179 | 0.010 |
Why?
| | Adenosine Monophosphate | 1 | 2001 | 88 | 0.010 |
Why?
| | Sodium | 1 | 2000 | 198 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2003 | 794 | 0.010 |
Why?
| | Electric Conductivity | 1 | 1998 | 85 | 0.010 |
Why?
| | NF-kappa B | 1 | 2002 | 676 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2002 | 892 | 0.010 |
Why?
| | Proteins | 1 | 2002 | 1024 | 0.010 |
Why?
| | Brain | 1 | 1998 | 3009 | 0.000 |
Why?
|
|
Sparagna's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|